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Abstract
HIV-related stigmatization and adversarial growth are known to influence health outcomes in people living with HIV. But not 
much is known how these psychosocial factors are related to each other and how they interact to influence health outcomes. 
We tested whether the effect of experienced and internalized stigma on mental health and self-rated health is mediated by 
adversarial growth, and whether each of these factors is uniquely associated with health outcomes. In our sample of 839 
people aging with HIV in Germany based on a cross-sectional study design we did not find an indirect effect of experienced 
HIV stigma on health outcomes and a very small indirect effect of internalized HIV stigma. All variables were significant 
predictors of health outcomes in multiple regression analyses.
Keywords HIV stigma · Posttraumatic growth · Mental health · Self-rated health · Mediation
Resumen
Se sabe que el estigma y el crecimiento postraumático asociados al VIH influyen en los indicadores del estado de salud de 
las personas que viven con el virus. Sin embargo, se desconoce cómo estos factores psicosociales se relacionan entre sí, y 
cómo interactúan sobre los indicadores del estado de salud. En este estudio comprobamos si los efectos de la experiencia e 
internalización del estigma sobre la salud mental y la evaluación subjetiva del estado salud están mediados por el crecimiento 
postraumático, así como el impacto único de cada uno de estos factores sobre los indicadores de salud. Usando un diseño 
de estudio transversal en una muestra de 839 personas que viven con VIH en Alemania, no encontramos un efecto indirecto 
del estigma experimentado en los indicadores de salud, pero sí, un efecto indirecto muy pequeño del estigma internalizado. 
Todas las variables se mostraron predictores significativos de los resultados de salud en un análisis de regresión múltiple.
Introduction
Even in the era of antiretroviral treatment (ART), living with 
an HIV infection is characterized by impaired mental and 
physical health, and negative and positive psychosocial fac-
tors are known to influence health outcomes among people 
living with HIV (PLWH) [1, 2]. HIV-related stigmatization 
and growth processes after a ‘traumatic’ HIV diagnosis are 
two of these factors. Not much is known about how these 
two factors are related to each other and whether they inter-
act to influence health outcomes.
HIV‑related Stigma and Health Outcomes
Since it was first described HIV infection is a highly stig-
matized condition [3] and PLWH are exposed to more 
stigmatization than people living with other diseases [4]. 
This is true even since the advent of ART normalized HIV 
infection to a manageable chronic disease, though there is 
evidence that ART has the potential to diminish the stigma-
tization of PLWH [5]. A widely agreed upon definition of 
the stigma concept in general or HIV stigma in particular 
does not exist [6], however, most authors define stigma via 
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its manifestations or mechanisms (e.g. [7]). While stigma 
can manifest on the level of the stigmatizer, the stigmatized 
and the society, we will focus here on the perspective of the 
target of stigmatization. In their HIV Stigma Framework, 
Earnshaw and Chaudoir [8] differentiated between three 
manifestations or mechanism of stigma that affect the stig-
matized: 1) experienced stigma (ES; the actual experience of 
discrimination), 2) anticipated stigma (AS; the expectation 
of experiencing discrimination in the future), and 3) inter-
nalized stigma (IS; the endorsement of stigmatizing beliefs 
and feelings about oneself like feelings of guilt, shame and 
self-blaming). The different mechanisms of HIV stigma 
are neither conceptually nor statistically independent from 
each other. Indeed, the authors reported significant correla-
tions between AS and ES and between IS and AS but could 
not detect a significant relationship between IS and ES [9]. 
However, an innovative study, using an experience sample 
approach could demonstrate that the experience of discrimi-
native acts predicted increases in IS among PLWH [10].
The detrimental consequences of HIV-related stigmatiza-
tion for the health of PLWH are well documented. Extensive 
research shows that stigma is related to distress, depression 
and anxiety, overall quality of life, physical health, social 
support, adherence to antiretroviral therapy and other health 
behaviors, as well as access to and usage of health services 
in PLWH (for a review see [11]). While associations with 
all health indicators are of substantial dimensions, relation-
ships with mental health are generally stronger than with 
physical health outcomes. Meta-analyses calculated effect 
sizes ranging from 0.30 to 0.41 between stigma and depres-
sion and/or anxiety symptoms while effect sizes for physical 
health ranged from − 0.19 to − 0.32 [11, 12]. Unfortunately, 
these meta-analyses were not able to differentiate between 
stigma manifestations, as most instruments to assess stigma 
in PLWH are not designed to assess all three manifestations 
separately. Research on stigma that employs Earnshaw and 
Chaudoir’s HIV Stigma Framework is still in an early stage 
of development. However, a study by Earnshaw and col-
leagues demonstrated that all three stigma manifestations are 
independently related to various health outcomes. IS showed 
the biggest association with mental health aspects while ES 
was strongest related to physical health outcomes [9]
Adversarial Growth in People Living with HIV 
and Health Outcomes
Experiencing an adverse, potentially traumatic event like the 
diagnosis of an HIV infection is not necessarily restricted to 
negative psychological or health outcomes. In the contrary, 
there is evidence that people experience positive changes in 
their life while dealing with an adverse event. These changes 
are referred to in the literature as growth processes and come 
under many interchangeable terms like e.g. adversarial 
growth (AG), posttraumatic growth (PTG), or benefit find-
ing. For this paper, we will use the broader term “adversarial 
growth” first proposed by Linley and Joseph [13]. These 
authors define AG as the result of “struggling with adver-
sity”, AG in this respect relates to any changes following an 
adverse event, which “propel the individual to a higher level 
of functioning than that which existed prior to the event” 
[13]. This way we avoid the connotations that come with 
the clinical term ‘posttraumatic’ and stress the fact that the 
growth processes we are researching are not depending on 
the existence of ‘trauma’ but on a variety of adverse events.
Different theoretical models were proposed to explain the 
AG phenomenon, however, according to Sawyer et al. most 
models have in common that “the experience of a highly 
stressful or traumatic event violates an individual’s basic 
beliefs about the self and the world and that some type of 
meaning making or cognitive processing to rebuild these 
beliefs and goals occur, resulting in perceptions that one 
has grown through the process” (p. 437) [14]. Dimensions 
on which growth is occurring also vary across models, but 
most models and instruments embrace these three dimen-
sions: 1) changes in personal/inner strength, 2) changes in 
life philosophy or appreciation of life and 3) changes in rela-
tionships with others [15].
Originally, theories on AG were not concerned with 
potential health outcomes of the growth process. However, 
some studies analyzed these relationships between AG and 
mental and physical health. In general, the research results 
regarding this question are inconclusive [16] and there are 
considerably less empirical studies on this research question 
compared to studies on HIV stigma and health outcomes. 
The best empirical evidence exists for an inverse relationship 
between adversarial growth and depression in PLWH with 
the majority of studies showing significant relationships 
between both variables [17], with small to moderate effect 
sizes [18]. It is difficult to identify similar trends in respect 
to anxiety symptoms or other health outcomes because of 
the small number of studies researching these relationships 
[19]. Existing studies show a significant inverse relationship 
between AG and anxiety [19, 20] and a significant positive 
relationship with the physical functioning domain of qual-
ity of life [21], while another study reports a non-signifi-
cant relationship with self-rated health [22]. In a sample 
of elderly PLWH AG was associated with better cognitive 
aging [23].
The Relationship Between Stigma and Adversarial 
Growth
Research on the relationships between stigma manifestations 
and AG is just recently emerging. In models of AG stigma 
is not considered as a variable as these models do not focus 
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on growth processes elicited by health-related conditions 
like HIV/AIDS.
In the five published empirical studies that report rela-
tionships between HIV-related stigma and AG, stigma is 
in each case conceptualized as a predictor of AG. Each of 
these studies hypothesize a negative effect of stigma on AG 
based on the assumption that stigma is hindering growth 
processes. In the theoretically most elaborate approach, 
Kamen et al. [24] propose a direct and an indirect way of 
how stigma has a negative impact on growth processes based 
on Tedeschi and Calhoun’s seminal model of PTG [15]. The 
indirect effect hypothesizes that stigma hinders HIV status 
disclosure, which is essential for receiving social support, 
which is again essential for growth to occur. In a direct way 
stigma may “decrease PTG by hampering individuals’ abil-
ity to appropriately express emotion, develop an enhanced 
understanding of their trauma, and begin the process of 
meaning-making” (p. 127) [24]. Other conceptualizations 
of the relationship between stigma and AG are also possible. 
Garrido–Hernansaiz and colleagues referred to theoretical 
assumptions about the role of distress in the growth pro-
cess explaining their surprising positive correlation between 
stigma and AG [25]. While, in the times of a normalization 
of HIV the infection itself may not be able to generate stress 
levels that are sufficiently high to initiate growth processes, 
the existence of stigma could contribute to a stress level that 
is sufficient for growth processes to occur.
The results of these studies are inconclusive concerning 
the relationship between stigma and AG in PLWH. Four of 
these studies showed small to medium sized negative cor-
relations between measures of HIV-related stigma and AG. 
While in two studies bivariate correlations between both 
variables were statistically significant (r > 0.20), the rela-
tionship was non-significant when controlled for other vari-
ables like resilience or social support [22, 26]. Kamen et al. 
reported smaller correlations between adversarial growth 
and HIV stigma and disclosure behavior, but after adding 
social support to the regression term only disclosure behav-
ior stayed a significant predictor of adversarial growth [24]. 
Dibb, however, did not find a significant bivariate relation-
ship between AG and HIV stigma but a surprisingly high 
bivariate negative association between AG and disclosure 
regret (r = − 0.46) [27]. Contrarily, Garrido–Hernansaiz and 
colleagues reported positive direct and indirect relationships 
between IS and AG using a structural equation modelling 
approach [25].
Current Study
The current study focusses on the associations between 
the two HIV stigma manifestations ES and IS, and AG and 
health outcomes in people living with HIV. Based on previ-
ous research on the associations between HIV stigma and 
AG we will first analyze if AG works as a mediator between 
these stigma manifestations and two health outcomes, men-
tal health and self-rated health. This involves the testing of 
four hypotheses: H1) AG (partially) mediates the effect of 
ES on mental health. H2) AG (partially) mediates the effect 
of ES on self-rated health. H3) AG (partially) mediates the 
effect of IS on mental health. H4) AG (partially) mediates 
the effect of IS on self-rated health.
In a second step we will analyze the unique independent 
effects of ES, IS and AG on both health outcomes. This 
involves the testing of six hypotheses: H5) ES is an inde-
pendent predictor of mental health. H6) ES is an independ-
ent predictor of self-rated health. H7) IS is an independent 
predictor of mental health. H8) IS is an independent predic-
tor of self-rated health. H9) AG is an independent predictor 




The study 50plushiv was a cross-sectional, exploratory study 
with a quantitative and a qualitative study arm to describe 
the health, living conditions and needs of people aging with 
HIV and AIDS in Germany conducted in 2013–2014. In this 
paper, we will report results from the quantitative study arm. 
Eligible participants were all people with a self-reported 
diagnosis of HIV, 50 years old or older and living in Ger-
many. The questionnaire was provided as an online question-
naire and as a paper pencil questionnaire. Several online and 
offline strategies were used to reach potential participants.
A total of 907 people who met the eligibility criteria 
completed either the paper (n = 499) or the online (n = 408) 
questionnaire. We eliminated all participants with missing 
data on one of the study variables we used for the mediation 
and regression analyses (n = 68). Our final analysis sample 
consisted of n = 839 participants.
Measures
Sociodemographic Variables
Sociodemographic variables were used for descriptive pur-
poses and as covariates in the multiple regression analyses. 
These variables comprise age, gender, sexual orientation, 
HIV transmission group, duration of HIV infection and 
education. Age and duration of HIV infection were used as 
metric variables in the regression analyses, gender, educa-
tion, sexual orientation and HIV transmission group were 
dummy coded for regression analyses.
1040 AIDS and Behavior (2021) 25:1037–1046
1 3
Experienced HIV Stigma
We assessed ES with a self-constructed index that we used 
in previous unpublished research because we were not con-
vinced by the wording and content of existing measures (see 
Online Appendix for items). Participants were asked to rate 
how often they experienced various forms of stigmatiza-
tion and discrimination because of their HIV infection on a 
5-point Likert scale (never–very often). Items were opera-
tionalizing blaming and shaming (e.g. “Friends are blam-
ing me for my HIV infection”), distancing (“Potential (sex) 
partners are rejecting me because of my HIV infection”) and 
structural stigma (“I was denied medical aid or was treated 
unfair at a physician’s practice, hospital or other health insti-
tution”). We assigned scores from 0 (never) to 4 (very often) 
and added scores to a single sum score with a possible range 
from 0 to 28. Our index of experienced stigma with 7 items 
had an acceptable internal consistency with Cronbach’s 
alpha = 0.78.
Internalized HIV Stigma
IS was assessed using the negative self-image scale of the 
HIV Stigma Scale [28] in the German translation [29]. The 
HIV Stigma Scale is the most widely used scale to measure 
HIV-related stigma from the perspective of the stigmatized 
[12]. For this study, we used 6 out of 7 items from the origi-
nal scale; one item was dropped due to human error in the 
construction of the questionnaire. Responses were recorded 
on a 4-point Likert scale (strongly agree–strongly disagree). 
Internal consistency for our scale of 6 items was good: Cron-
bach’s alpha = 0.89.
Adversarial Growth
We used an abbreviated version of the Silver Lining Ques-
tionnaire (SLQ) [30, 31] to measure adversarial growth. 
The SLQ-38 is a 38-item questionnaire constructed to 
measure growth processes following the diagnosis of a 
chronic illness. While the authors Sodergreen and Hyland 
claim that the SLQ-38 is unidimensional, Bride et al. [32] 
revisited the factor structure of the instrument and pre-
sented an abbreviated instrument with 24 items loading 
on five factors. As space limitations in our survey did not 
allow the integration of a 24-item scale the instrument was 
even more abbreviated by selecting only the two highest 
loading items from four of the five factors proposed by 
Bride et al. a) improved personal relationships, b) greater 
appreciation for life, c) personal inner strength and d) 
changes in life philosophy. In this study a 4-point Lik-
ert scale (strongly agree – strongly disagree) was used as 
suggested by Sodergreen & Hyland of this paper to avoid 
the middle “not sure” option. We also followed Bride 
et al.’s suggestion to use continuous scoring instead of 
Sodergreen and Hyland’s dichotomization of the response 
options. Items were translated by the authors using stand-
ard procedures. Preliminary factor analyses showed that 
all 8 items loaded highly (> 0.70) on one shared factor 
(principal component analysis: Eigenvalue = 4.8, explains 
59.8% of variance). The 8-item scale showed excellent 
internal consistency with Cronbach’s alpha = 0.90.
Mental Health
The PHQ-4 scale, an ultra-brief screening instrument for 
Major Depression and other forms of depression as well 
as for Generalized Anxiety Disorder and other anxiety and 
panic disorders [33], was used to measure mental health. 
The PHQ-4 items are asking for the frequency of symp-
toms experienced in the last 14 days. Responses are scored 
from 0 (“not at all”) to 3 (“nearly every day”) and added to 
obtain a simple sum score ranging from 0 to 12. Scores are 
categorized in four groups for descriptive purposes: normal 
(0–2), mild (3–5), moderate (6–8), severe (9–12). While we 
use these categorizations for descriptive purposes, the sum 
score was used as an “overall measure of symptom burden, 
as well as impairment and disability” [33] in our mediation 
and regression analyses. Cronbach’s alpha for the PHQ-4 in 
our sample was excellent: alpha = 0.90.
General Health Status
We assessed general health status with the item “In general, 
how would you rate your health?” Answers were recorded on 
a 5-point Likert scale (excellent–poor). This measurement of 
self-rated health is widely used in epidemiological studies, 
is part of various quality of life instruments and proved to be 
predictive of mortality in diverse populations [34].
Statistical Analyses
All statistical analyses were conducted with IBM SPSS Sta-
tistics 25. We used the PROCESS version 3.3 procedure for 
SPSS by Hayes [35] to perform simple mediation analy-
ses (model 4) to detect mediation effects between stigma 
manifestations, adversarial growth and health outcomes. To 
quantify independent effects of stigma manifestations and 
adversarial growth on health outcomes a multiple regression 
analysis was conducted for each health outcome control-
ling for age, education (dummy-coded: 10 years and less 
vs. more than 10 years), gender (dummy-coded: male vs 
female), sexual orientation (dummy-coded: heterosexual vs 
homosexual) and duration of HIV infection.
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Results
Sample Characteristics and Intercorrelations 
Between Study Variables
Sample characteristics and descriptive statistics for the study 
variables can be found in Table 1. All study variables cor-
relate significantly with each other in bivariate correlation 
analyses except experienced HIV stigma and adversarial 
growth (r = 0.032; p > 0.05). The highest correlations are 
found between mental health and self-rated health (r = 0.514; 
p < 0.001) and between internalized HIV stigma and mental 
health (r = 0.480; p < 0.001) (see Table 2).
Mediation Analyses
Results of the mediation analyses can be found in Table 3 
and in Fig. 1. ES was not a significant predictor of AG in the 
mediation analyses on mental health (B = 0.006; p = 0.373) 
and self-rated health (B = 0.006; p = 0.393) and both analy-
ses did not show a significant indirect effect (for the mental 
health model: effect = − 0.005; 95% CI [− 0.015; 0.005] 
and for self-rated health: effect = − 0.001; 95% CI [− 0.005; 
0.002]. Each of the mediation models regarding IS showed 
a significant indirect effect, for mental health the effect is 
0.075 [95% CI (0.019; 0.143)] and for self-rated health the 
effect is 0.032 [95% CI (0.013; 0.054)]. 
Regression Analyses
Table 4 shows the results of the regression analyses. After 
controlling for age, gender, education, sexual orientation, 
and duration of HIV infection, ES, IS and AG were signifi-
cant predictors of mental health and self-rated health.
Discussion
The goal of this study was to further our understanding of 
the associations between stigma manifestations, adversar-
ial growth and health outcomes. We tested ten hypotheses 
using mediation analyses and multiple regression analyses. 
Based on our results we have to reject hypotheses H1 and 
H2, as ES is not a significant predictor of AG and thus 
AG cannot mediate the effect of ES. Hypotheses H3 and 
H4 are confirmed by our data. IS has a significant indi-
rect effect on mental health and self-rated health through 
AG in our mediation analyses, but both indirect effects 
are very small. Hypotheses H5 to H10 concerning the 
unique effects of the two stigma manifestations and AG 
on health outcomes are all confirmed by our data. ES, IS 
and AG each were significantly related to mental health 
and self-rated health in multiple regression analyses after 
controlling for age, education, gender, sexual orientation 
and duration of HIV infection.
Table 1  Descriptive statistics for sociodemographic and study vari-
ables (n = 839)
 % Mean (Standard 
deviation)
Range
Age 56.9 (6.3) 50–83
 50–59 years 73.5
 60–69 years 20.2









Education 12.4 (4.0) 3.3–21
 10 years or less 55.3




 i.v. drug use 3.3
 Blood products 3.4
 Other/don’t know 2.7




 21 years and longer 37.0
Experienced HIV stigma 3.5 (3.9) 0–24
Internalized HIV stigma 1.5 (0.7) 1–4
Adversarial growth 2.3 (0.8) 1–4
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Theoretical Implications
While previous studies already looked into the relation-
ship between HIV stigma and AG, we were the first to 
analyze the associations between AG and two of the three 
stigma mechanisms proposed by Earnshaw and Chaudoir 
[8, 9] and test mediations models to understand whether 
AG (partially) mediates the effect of stigma on health out-
comes. In our sample IS and ES were unexpectedly in a 
different way related to AG. While IS was significantly 
correlated with AG and the magnitude of the association 
was equivalent to that found in other studies [22, 26], ES 
was in correlation and mediation analyses positively but 
statistically not significantly associated with AG. We could 
not identify any previous study that reported a correlation 
between a measure of ES and AG but one study reported 
a positive association between a measure of HIV-related 
stigma and AG [25]. In this study the measure of IS was 
associated positively associated with AG using structural 
equation modelling in a longitudinal research design. The 
authors of this study argue that stigma functions as an 
(additional) stressor and elevated stress levels are a pre-
requisite for growth processes (see introduction). While 
in this study an instrument measuring IS and not ES was 
used and this result in regard to IS stands in contrast to 
the results of any other study using a similar measure of 
IS, including our study, the notion that stigma-induced 
stress can foster growth processes should not be easily 
Table 2  Intercorrelation matrix of study variables (n = 839)
Correlations in bold are significant at the 0.001 level
1 2 3 4
1 Experienced HIV stigma
2 Internalized HIV stigma 0.341
3 Adversarial growth 0.032 − 0.216
4 Mental health 0.346 0.480 − 0.179
5 Self-rated health 0.287 0.289 − 0.174 0.514
Table 3  Results of the mediation analyses (n = 839)
c total effect of predictor on outcome, a effect of predictor on media-
tor, b effect of mediator on outcome controlling for predictor, c’ effect 
of predictor on outcome controlling for mediator (direct effect of pre-
dictor). ES experienced stigma, AG adversarial growth, MH mental 
health, SRH self-rated health, IS internalized stigma
Predictor Outcome B (SE) t p
c ES MH 0.263 (0.026) 10.074  < 0.001
a ES AG 0.006 (0.007) 0.891 0.373
b ES|AG MH − 0.768 (0.131) − 5.887  < 0.001
c’ AG|ES MH 0.268 (0.025) 10.695  < 0.001
c ES SRH 0.064 (0.007) 8.634  < 0.001
a ES AG 0.006 (0.007) 0.856 0.393
b ES|AG SRH − 0.215 (0.040) − 5.438  < 0.001
c’ AG|ES SRH 0.065 (0.007) 8.933  < 0.001
c IS MH 2.101 (0.152) 13.831  < 0.001
a IS AG − 0.234 (0.036) − 6.567  < 0.001
b IS|AG MH − 0.320 (0.122) − 2.626  < 0.01
c’ AG|IS MH 2.026 (0.153) 13.230  < 0.001
c IS SRH 0.371 (0.044) 8.372  < 0.001
a IS AG − 0.235 (0.036) − 6.609  < 0.001
b IS|AG SRH − 0.137 (0.040) − 3.393  < 0.01
c’ AG|IS SRH 0.338 (0.045) 7.554  < 0.001
Fig. 1  Mediation models with standardized coefficients for effects 
(n = 839). Note: Coefficients marked with ***are significant at the 
.001 level, coefficients marked with **are significant at the 0.01 level
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dismissed. The experience of stigma and discrimination 
indeed leads to stress reactions for the stigmatized indi-
vidual and thus can be understood as a stressor [36], and 
IS, too, is associated with increased stress levels for the 
individual [37]. However, while both ES and IS work 
as a stressor for the stigmatized individual, we propose 
that only the stress associated with ES is able to instigate 
growth processes. IS is defined by feelings and cognitions 
like shame, self-blame, and worthlessness [8, 9], and these 
feelings and cognitions hinder growth processes: “PLWH 
who feel shameful about their HIV status may struggle 
to develop or maintain positive cognitions about their 
HIV“ (9, p. 1786). In Joseph et al.’s affective-cognitive 
processing model of post-traumatic growth two appraisal 
processes characterize the intrusion phase: a) ruminative 
brooding and b) reflective pondering [38]. While reflective 
pondering is required for the reappraisal of the adverse 
event and to eventually leave the intrusion phase, rumi-
native brooding can reinforce ‘negative emotional states 
such as guilt, shame or anger’ and ‘prolongs the intrusion 
phase’ [38, p. 322]. While both IS and ES was associated 
with rumination in previous studies [39, 40] and it is likely 
that both intensify ruminative brooding in the intrusion 
phase, ES leaves space for reflective pondering, but IS 
does not.
The fact that our measure of ES was not significantly 
related to AG can be explained taking the age of our par-
ticipants and the lack of a time frame for our measure of ES 
into account. Our participants are aging with HIV and are 
at least 50 years or older, over 70% were diagnosed with 
HIV more than 10 years ago. Previous research showed that 
levels of stigma decrease with age and time since diagnoses 
[41, 42], while a similar effect for AG does not exist [17]. 
Our instrument to measure ES did not specify a time frame 
but asked for the frequency with which stigmatizing epi-
sodes were experienced by the participant at the moment 
or in the past. It is possible that stigmatizing events were 
either underreported due to the open time frame, or that 
these events took place so long ago that they did not have 
any effect on current AG levels. Moreover, it is possible 
that these events took place in the IS pre-growth phase, thus 
increasing IS levels instead of fostering growth. Our cross-
sectional study design is not able to shed light on these pro-
cesses and interactions of stigma and AG over the course of 
HIV infection.
While IS was strongly correlated with AG, the small 
mediation effect we detected on either health outcome does 
not support the hypothesis that AG is buffering the adverse 
effect of HIV-related stigma on mental health and self-rated 
health. However all stigma manifestations and AG had a 
unique impact on health outcomes. Stigma manifestations 
had higher impacts on health outcomes compared to AG, and 
AG had a higher impact on self-rated health than on mental 
health. We were able to replicate Chaudoir et al.’s findings 
that IS is stronger related to mental health than ES and, how-
ever less distinctive, ES is stronger related to physical health 
outcomes. The less distinctiveness of the latter finding might 
be due to the measure of physical health we chose. Self-rated 
health is not an exclusive measure of physical health, and 
studies show that the presence of depression and depres-
sive symptoms has a substantial impact on the assessment 
[43]. This might explain the high correlation found between 
self-rated health and depressive and anxious symptoms in 
our sample.
Limitations
Our study has several limitations. We used data from a 
cross-sectional study, which means we cannot infer cau-
sality. Furthermore, mediation analyses require longitudi-
nal data to obtain valid results, our results are thus to be 
interpreted with caution and seen as exploratory findings 
which need confirmation from studies with longitudinal 
designs. The instruments we used to assess HIV stigma 
and AG show some limitations too. While all previous 
studies on the associations between HIV stigma and AG 
used the Posttraumatic Growth Inventory [44], we chose 
the Silver Lining Questionnaire because this instru-
ment was designed specifically to assess disease-related 
growth processes. Furthermore, we shortened the orig-
inal SLQ from 36 to 8 items due to space restrictions. 
While the face validity of our instrument is still high, 
we do not know whether the shortened instrument was 
able to catch all aspects of adversarial growth that were 
Table 4  Stigma manifestations 
and adversarial growth as 
predictors of mental health 
and self-rated health: multiple 
regression models (n = 839)
Coefficients in bold are significant at the 0.001 level. All models are adjusted for age, gender, education, 
sexual orientation, and time since HIV diagnosis (entered as block 1)
Mental health Self-rated health
β B Std F T β B Std F T
Experienced
HIV stigma
0.192 0.146 0.024 6.058 0.215 0.048 0.008 6.219
Internalized
HIV stigma
0.390 1.709 0.146 11.742 0.192 0.245 0.046 5.280
Adversarial
growth
− 0.106 − 0.427 0.121 − 3.527 − 0.150 − 0.177 0.039 − 4.577
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assessed in the original version of the instrument or in 
similar instruments. We further found that the selected 
eight items loaded highly on one shared factor; a result 
already reported by the authors of the original 36 item 
scale [30]. Our results do not support the factor solution 
proposed by Bride et al. [32], though we chose only the 
two items that loaded highest on four of their five extracted 
factors—a result that could be also attributed to the much 
smaller number of items we used for our factor analysis. 
The instrument we used to measure ES was an ad hoc 
scale. While this measure shows a high face validity, we 
do not know whether it captures all relevant aspects of ES.
Practical Implications
Our results show that ES, IS and AG have each a unique 
effect on health outcomes of PAWH. Interventions that 
focus on decreasing levels of ES or IS in PLWH can be 
effective in improving health outcomes in this population. 
The same applies for interventions that foster growth pro-
cesses. While interventions that are specifically designed 
for this aim are still rare and lack rigorous evaluation of 
their effectiveness, a recent meta-analysis could demon-
strate that existing psychosocial interventions can increase 
levels of AG [45]. Our study also implies that fostering 
growth processes to buffer the negative impact of internal-
ized stigma on health outcomes may not be an effective 
strategy, but interventions to reduce levels of IS, can help 
to enable growth processes in PLWH.
Implications for Future Research
Research on stigma generally lacks theoretical conceptu-
alizations to inform research designs and evidence-based 
interventions [46]. Compared to the literature on AG, 
which is characterized by several theoretical approaches 
with elaborate conceptualizations of the growth process, 
and its prerequisites and consequences, there are only a few 
similar theoretical elaborations describing, for example, the 
process of the internalization of stigma or the mechanisms 
by which stigma leads to adverse health outcomes [39]. To 
improve our understanding of the trajectories and interac-
tions between HIV stigma manifestations and AG methodo-
logically sound longitudinal research designs are needed that 
are guided by theoretical frameworks. Ideally, these studies 
would start with patients who are recently diagnosed with 
HIV and monitor stigma manifestations, AG and health out-
comes over an extended period of several years.
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Appendix
Experienced HIV stigma index
How often have you experienced the following in the 
past?
(very often–often–sometimes–rarely–never)
Friends and acquaintances reproach me for my HIV 
infection.
Friends and acquaintances think badly of me because of 
my HIV infection.
Friends and acquaintances pity me excessively because 
of my HIV infection.
(Sex) partners reject me because of my HIV infection.
Because of my HIV infection, friends and acquaintances 
avoid me.
Because of my HIV infection, family members avoid me.
I am denied medical help because of my HIV infection, 
or I am treated unfairly when visiting a doctor, a hospital or 
other places of the health system.
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